List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 168 studies with search of:   "Epirubicin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
Condition: Adenocarcinoma
Interventions: Drug: Epirubicin with Cyclophosphamide, followed by a Taxane;   Drug: Epirubicin with a Taxane
2 Recruiting Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Epirubicin;   Drug: Epirubicin;   Drug: Docetaxel
3 Recruiting Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Pegylated liposomal doxorubicin (Caelyx);   Drug: Epirubicin
4 Recruiting Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Trastuzumab;   Drug: Bevacizumab
5 Recruiting Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Epirubicin, cyclophosphamide and docetaxel;   Drug: docetaxel, cyclophosphamide
6 Recruiting A Phase I, Open-Label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors.
Condition: Cancer
Interventions: Drug: Doxorubicin;   Drug: Pazopanib (GW786034);   Drug: Epirubicin
7 Recruiting Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: docetaxel and epirubicin;   Drug: docetaxel and epirubicin plus endostatin
8 Completed Study of Docetaxel in Breast Cancer Patients
Condition: Breast Neoplasms
Interventions: Drug: epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile;   Drug: epidoxorubicine, docetaxel, ciclophosphamide, methotrexate, fluorouracile;   Drug: epidoxorubicine, docetaxel, cyclophosphamide
9 Recruiting Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: Epirubicin, cyclophosphamide, docetaxel;   Drug: Epirubicin, cyclophosphamide, 5-fluorouracil, docetaxel
10 Recruiting Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Epirubicin;   Drug: Bevacizumab
11 Recruiting Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
Conditions: Gastric Cancer;   Esophageal Cancer;   Tumors
Interventions: Drug: Epirubicin;   Drug: Carboplatin;   Drug: Capecitabine
12 Completed Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Capecitabine;   Drug: Epirubicin;   Drug: Docetaxel
13 Active, not recruiting Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes
Condition: Breast Cancer
Interventions: Drug: Cyclophosphamide, Epirubicin, Paclitaxel;   Drug: Epirubicin, Paclitaxel, Filgrastim
14 Recruiting Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Condition: Early-Stage Breast Cancer
Interventions: Drug: Epirubicin;   Drug: Docetaxel;   Drug: Capecitabine
15 Active, not recruiting Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
Conditions: Breast Cancer;   Adenocarcinoma of the Breast
Intervention: Drug: epirubicin, cyclophosphamide, Paclitaxel,
16 Recruiting A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: epirubicin - cyclophosphamide / docetaxel;   Drug: epirubicin - cyclophosphamide / docetaxel + bevacizumab;   Drug: paclitaxel;   Drug: paclitaxel + everolimus (RAD001);   Drug: epirubicin - cyclophosphamide / docetaxel + trastuzumab;   Drug: epirubicin - cyclophosphamide / docetaxel + lapatinib
17 Completed EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: epirubicin;   Drug: docetaxel;   Drug: capecitabine
18 Active, not recruiting Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: epirubicin hydrochloride;   Drug: paclitaxel
19 Recruiting Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
Condition: Neoplams, Advanced
Interventions: Drug: valproic acid;   Drug: epirubicin;   Drug: 5-fluorouracil;   Drug: Cyclophosphamide.
20 Active, not recruiting Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Conditions: Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Epirubicin;   Drug: Capecitabine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services